Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hanai

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Journal of Applied Toxicology : JAT|December 1, 1984
Morphological and immunocytochemical study of rat pancreatic beta cell changes induced by cyclizineN Hanai
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|May 1, 1991
[Gangliosides modulate function of EGF receptor]N Hanai
Cancer Research|September 1, 1986
Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lungN Hanai, K Shitara, H Yoshida
International Journal of Oral and Maxillofacial Surgery|March 31, 2024
Comment on "Ectopic thymic carcinoma of the parotid gland"E Sasaki, H Terada, N Hanai
Cancer Research|October 1, 1986
Distribution of a squamous cell lung carcinoma-associated antigen, KA-32, in human tissues and sera defined by monoclonal antibody KM-32N Hanai, K Shitara, H Yoshida
Anticancer Research|May 1, 1993
Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227K Shitara, N Hanai, H Yoshida
Cancer Chemotherapy and Pharmacology|August 19, 2000
Recombinant antibodies against ganglioside expressed on tumor cellsN Hanai, K Nakamura, K Shitara
Anticancer Research|January 1, 1992
Development of anti-idiotype monoclonal antibodies for Sialyl Le(a) antigenA Furuya, H Yoshida, N Hanai
Cancer Research|March 1, 1987
Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93K Shitara, N Hanai, H Yoshida
Cancer Immunology, Immunotherapy : CII|August 14, 2001
Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functionsK Nakamura, Y Tanaka, K Shitara, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Journal of Applied Toxicology : JAT|December 1, 1984
Morphological and immunocytochemical study of rat pancreatic beta cell changes induced by cyclizineN Hanai
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|May 1, 1991
[Gangliosides modulate function of EGF receptor]N Hanai
Cancer Research|September 1, 1986
Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lungN Hanai, K Shitara, H Yoshida
International Journal of Oral and Maxillofacial Surgery|March 31, 2024
Comment on "Ectopic thymic carcinoma of the parotid gland"E Sasaki, H Terada, N Hanai
Cancer Research|October 1, 1986
Distribution of a squamous cell lung carcinoma-associated antigen, KA-32, in human tissues and sera defined by monoclonal antibody KM-32N Hanai, K Shitara, H Yoshida
Anticancer Research|May 1, 1993
Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227K Shitara, N Hanai, H Yoshida
Cancer Chemotherapy and Pharmacology|August 19, 2000
Recombinant antibodies against ganglioside expressed on tumor cellsN Hanai, K Nakamura, K Shitara
Anticancer Research|January 1, 1992
Development of anti-idiotype monoclonal antibodies for Sialyl Le(a) antigenA Furuya, H Yoshida, N Hanai
Cancer Research|March 1, 1987
Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93K Shitara, N Hanai, H Yoshida
Cancer Immunology, Immunotherapy : CII|August 14, 2001
Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functionsK Nakamura, Y Tanaka, K Shitara, et al.
Pageof 10